Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 128,627,856
  • Shares Outstanding, K 1,478,821
  • Annual Sales, $ 32,753 M
  • Annual Income, $ 5,687 M
  • 60-Month Beta 0.99
  • Price/Sales 3.92
  • Price/Cash Flow 9.29
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 2.24
  • Number of Estimates 2
  • High Estimate 2.27
  • Low Estimate 2.20
  • Prior Year 1.90
  • Growth Rate Est. (year over year) +17.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.08 +7.28%
on 11/07/19
90.41 -3.79%
on 11/19/19
+4.90 (+5.97%)
since 11/06/19
3-Month
65.65 +32.49%
on 09/10/19
90.41 -3.79%
on 11/19/19
+19.36 (+28.63%)
since 09/06/19
52-Week
62.66 +38.81%
on 08/15/19
92.99 -6.46%
on 12/31/18
-3.35 (-3.71%)
since 12/06/18

Most Recent Stories

More News
Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer's Disease (CTAD) Meeting

- Today's AL002 presentation showcases the first data in humans with a TREM2 antibody

ALEC : 19.76 (+1.91%)
ABBV : 86.98 (+0.30%)
AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI(TM) (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced an agreement was reached with the pan-Canadian Pharmaceutical Alliance (pCPA) regarding SKYRIZITM (risankizumab)...

ABBV : 86.98 (+0.30%)
J&J Stock Witnesses Volatility in '19: What to Expect in 2020

Here we discuss the ups and downs of J&J's (JNJ) stock this year.

JNJ : 140.38 (+0.59%)
ABBV : 86.98 (+0.30%)
MRK : 88.85 (+0.11%)
RHHBY : 38.5700 (+0.36%)
Mission and AbbVie's Collaboration in Alzheimer's and Parkinson's Diseases Reaches Milestone

Mission Therapeutics ("Mission"), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), and AbbVie ("AbbVie")(NYSE: ABBV), a global, research-driven...

ABBV : 86.98 (+0.30%)
AbbVie (ABBV) Stock Moves -0.79%: What You Should Know

AbbVie (ABBV) closed the most recent trading day at $87.04, moving -0.79% from the previous trading session.

ABBV : 86.98 (+0.30%)
Abbvie Inc Has Returned 24.3% Since SmarTrend Recommendation (ABBV)

SmarTrend identified an Uptrend for Abbvie Inc (NYSE:ABBV) on September 12th, 2019 at $70.68. In approximately 3 months, Abbvie Inc has returned 24.28% as of today's recent price of $87.84.

ABBV : 86.98 (+0.30%)
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - December 02, 2019

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income...

ABBV : 86.98 (+0.30%)
CMRE : 8.89 (+0.45%)
CRWS : 6.76 (+0.60%)
AbbVie (ABBV) Up 10.3% Since Last Earnings Report: Can It Continue?

AbbVie (ABBV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ABBV : 86.98 (+0.30%)
Market Serves Up More Records for Thanksgiving

Market Serves Up More Records for Thanksgiving

FIX : 49.65 (+0.61%)
PEGA : 76.98 (-0.36%)
YEXT : 14.26 (-14.10%)
ROST : 113.91 (+0.37%)
LOCO : 15.98 (+0.95%)
ELF : 15.26 (+2.35%)
ABBV : 86.98 (+0.30%)
3 Stocks for Value Investors to Buy as Market Reaches New High

The stock market closed at a record high today as the DJIA rose over 42 points and the S&P 500 gained 0.4%.

BAC : 33.67 (+1.75%)
PNC : 153.81 (+1.06%)
JPM : 135.04 (+1.49%)
C : 75.81 (+1.47%)
SAH : 32.37 (+3.78%)
AGN : 186.37 (+0.16%)
ABBV : 86.98 (+0.30%)
COST : 294.95 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade ABBV with:

Business Summary

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation...

See More

Key Turning Points

2nd Resistance Point 88.09
1st Resistance Point 87.53
Last Price 86.98
1st Support Level 86.60
2nd Support Level 86.23

See More

52-Week High 92.99
Last Price 86.98
Fibonacci 61.8% 81.40
Fibonacci 50% 77.82
Fibonacci 38.2% 74.25
52-Week Low 62.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar